Source: ClinicalTrials.gov — U.S. National Library of Medicine — A database of privately and publicly funded clinical studies conducted around the world (U.S. National Library of Medicine, public domain).
This page lists clinical trials related to Diabetes Complications from the ClinicalTrials.gov database.
Trial Summary
- Total studies: 50
- Recruiting: 23
- Active, not recruiting: 5
- Completed: 10
- Other: 12
Results are refreshed periodically and may not reflect the most current information available from ClinicalTrials.gov.
Recruiting Trials
NCT00071526 — Urinary Vitamin C Loss in Diabetic Subjects
| Status | Recruiting |
| Phase | N/A |
| Sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Enrollment | 5000 |
| Study Type | OBSERVATIONAL |
| Conditions | Diabetes |
Several studies have reported that diabetic subjects have lower plasma vitamin C concentrations than non-diabetic subjects. Although urinary vitamin C loss in diabetic subjects was reported to be increased in two studies, these are difficult to interpret due to lack of controlled vitamin C intake, inadequate sampling, lack of control subjects, or methodology uncertainties in vitamin C assay and…
NCT01496625 — National Eye Institute Biorepository for Retinal Diseases
| Status | Recruiting |
| Phase | N/A |
| Sponsor | National Eye Institute (NEI) |
| Enrollment | 650 |
| Study Type | OBSERVATIONAL |
| Conditions | Age-Related Macular Degeneration; Diabetic Retinopathy; Von Hippel-Lindau Syndrome; Retinal Disease; Retinal Vein Occlusion |
Background:
- To understand diseases of the retina and the eye, information is needed about people with and without such diseases. Researchers want to study these people and follow them over time. They also want to study body tissues and blood to understand the nature of eye disease. Studying genes, cells, and tissues may help them understand why some people get eye problems and others do not…
NCT04621396 — The Next Generation Longitudinal Birth Cohort Diabetes Study
| Status | Recruiting |
| Phase | N/A |
| Sponsor | University of Manitoba |
| Enrollment | 600 |
| Study Type | OBSERVATIONAL |
| Conditions | Type 2 Diabetes; Gestational Diabetes Mellitus |
| Interventions |
The overall aim of this project is to understand the independent roles of maternal factors, intrauterine exposures, genetic factors, and postnatal environment on the development of obesity and youth-onset type 2 diabetes (T2D) in childhood.
NCT05463289 — ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Johns Hopkins University |
| Enrollment | 500 |
| Study Type | INTERVENTIONAL |
| Conditions | Type 1 Diabetes; Type 2 Diabetes; Cystic Fibrosis-related Diabetes |
| Interventions |
The purpose of this study is to determine if use of a nonmydriatic fundus camera using autonomous artificial intelligence software at the point of care increases the proportion of underserved youth with diabetes screened for diabetic retinopathy, and to determine the diagnostic accuracy of the autonomous AI system in detecting diabetic retinopathy from retinal images of youth with diabetes.
NCT05398783 — A Natural History Study of Metabolic Sizing in Health and Disease
| Status | Recruiting |
| Phase | N/A |
| Sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Enrollment | 2000 |
| Study Type | OBSERVATIONAL |
| Conditions | Metabolic Disorders; Cancer; Chronic Kidney Disease; Diabetes; Normal Physiology |
Background:
Scientists have long used simple measures (such as height and weight) to estimate how much a person s body uses food (calories) as energy, as commonly called the metabolic rate. But metabolism varies among people with similar body sizes. Scientists now believe the old formulas for estimating metabolic rates may not work well for all people. Researchers want to find more accurate wa…
NCT05498116 — Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | University of Colorado, Denver |
| Enrollment | 50 |
| Study Type | INTERVENTIONAL |
| Conditions | Albuminuria |
| Interventions | ; |
Kidney disease is a common problem among people with type 1 diabetes and can lead to disability, dialysis, and early death. Inflammation plays a key role in the development of kidney disease in type 1 diabetes and targeting leukotrienes, inflammatory chemicals the body releases in response to allergic reactions, may represent a promising therapy to slow the progression of diabetic kidney diseas…
NCT05569772 — Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
| Status | Recruiting |
| Phase | Phase 3 |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Enrollment | 252 |
| Study Type | INTERVENTIONAL |
| Conditions | Glucose Intolerance After a Recent History of Gestational Diabetes |
| Interventions | ; |
Gestational diabetes (GDM) is an important contributor to the increasing prevalence of type 2 diabetes (T2DM). Women with glucose intolerance in early postpartum are a particularly high-risk group with about 50% who will develop T2DM within 5 years after the delivery. Moreover, women with a history of GDM progress more rapidly to T2DM compared to women with similarly elevated glucose levels. Ea…
NCT07689214 — Normast3 for Adults With Diabetic Polyneuropathy
| Status | Recruiting |
| Phase | N/A |
| Sponsor | University of Roma La Sapienza |
| Enrollment | 40 |
| Study Type | INTERVENTIONAL |
| Conditions | Diabete Type 2 |
| Interventions | ; |
The goal of this clinical trial is to find out if a new supplement called Normast® 3 can help reduce nerve pain and improve nerve function in adults with diabetic polyneuropathy (DPN). DPN is a common complication of diabetes that damages nerves, often causing burning, tingling, or stabbing pain, as well as problems with the autonomic nervous system, which controls things like sweating and hear…
NCT06701721 — A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.
| Status | Recruiting |
| Phase | Phase 1 |
| Sponsor | Therini Bio Pty Ltd |
| Enrollment | 21 |
| Study Type | INTERVENTIONAL |
| Conditions | Diabetic Macular Edema; Diabetic Retinopathy |
| Interventions |
THN391-OPT-101 is a study assessing safety and preliminary efficacy of THN391 in patients with diabetic macular edema (DME) given as monotherapy.
NCT07614659 — Uppsala Self-Screening of Cardiovascular Health
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Johan Sundström |
| Enrollment | 45000 |
| Study Type | INTERVENTIONAL |
| Conditions | Cardiovascular Diseases; Hypertension; Dyslipidemias; Diabetes Mellitus; Atrial Fibrillation |
| Interventions |
U-SCREEN is a randomized controlled trial evaluating whether systematic home-based multimodal screening for cardiovascular risk conditions, offered to residents in Region Uppsala turning 50, 55, 60, 65, 70 or 75 years of age, can identify clinically actionable cardiovascular risk factors more effectively than usual care. Participants randomized to the screening arm receive a home blood pressure…
NCT06694558 — Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease
| Status | Recruiting |
| Phase | N/A |
| Sponsor | The Cleveland Clinic |
| Enrollment | 60 |
| Study Type | OBSERVATIONAL |
| Conditions | Chronic Kidney Disease(CKD); Type 1 Diabetes (T1D) |
This is a cross-sectional study in patients with Type 1 diabetes (TID) and chronic kidney disease (CKD) to test if time in range (TIR) affects the degree of hyperglycemia required for monocyte activation, podocyte injury, and assess if monocyte activation is attenuated by glucagon-like peptide (GLP-1) agonist treatment ex vivo.
NCT07024823 — A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
| Status | Recruiting |
| Phase | Phase 1 |
| Sponsor | AstraZeneca |
| Enrollment | 124 |
| Study Type | INTERVENTIONAL |
| Conditions | Chronic Kidney Disease |
| Interventions | ; ; |
This study will evaluate safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single ascending doses (SAD) and multiple ascending doses (MAD) of AZD4248 administered as an oral solution and intravenous (IV) infusion. Additionally, the study investigates the non-interventional feasibility of home measurement of serum creatinine in participants with diabetic kidney disease (D…
NCT07174245 — Pregnancy and Postpartum CGM in GDM
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Enrollment | 40 |
| Study Type | OBSERVATIONAL |
| Conditions | Gestational Diabetes |
| Interventions |
Gestational diabetes (GDM) is one of the most common complications of pregnancy, and up to one third of women with GDM will have abnormal blood sugars after their pregnancy. To screen for abnormal blood sugars, standard of care is a 4-12 week postpartum oral glucose tolerance test (OGTT). However only 17-60% of women actually have this test performed. This study is to assess continuous glucose …
NCT07115953 — Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Medtronic Vascular |
| Enrollment | 130 |
| Study Type | INTERVENTIONAL |
| Conditions | Hypertension; Vascular Diseases; Cardiovascular Diseases; Chronic Kidney Diseases; Diabetes Mellitus |
| Interventions |
The purpose of the SPYRAL SWYFT sub-study is to evaluate whether renal denervation with the Symplicity Spyral system performed in the main and first order branch renal arteries yields a shorter procedure time and is as effective in reducing blood pressure than the procedural approach used in the SPYRAL HTN-ON MED and SPYRAL PIVOTAL - SPYRAL HTN-OFF MED clinical studies in an uncontrolled hypert…
NCT07010250 — Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Enrollment | 146 |
| Study Type | OBSERVATIONAL |
| Conditions | ANCA Associated Vasculitis; Extramembranous Glomerulopathy; Nephrotic Syndrome, Minimal Change; Interstitial Nephritis; IgA Nephropathy |
The project is to explore in humans the hypothesis of the link between the alteration of tubulo-interstitial metabolism and the rate of deterioration of renal function by comparing various nephropathies.
NCT07247084 — A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Eli Lilly and Company |
| Enrollment | 3000 |
| Study Type | INTERVENTIONAL |
| Conditions | Obesity |
| Interventions | ; |
The purpose of this study is to evaluate tirzepatide within a real-world setting to assess body weight loss and incidence of type 2 diabetes in adults without diabetes who have obesity and at least one weight-related comorbid condition. Participation in the study will last about 260 weeks.
NCT07354477 — Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation
| Status | Recruiting |
| Phase | Phase 2 |
| Sponsor | Qlaris Bio, Inc. |
| Enrollment | 14 |
| Study Type | INTERVENTIONAL |
| Conditions | Non-proliferative Diabetic Retinopathy (NPDR); Open-angle Glaucoma (OAG); Normal Tension Glaucoma (NTG) |
| Interventions | ; |
Pilot, single-site, prospective study of QLS-111 0.015 % in subjects with NPDR, OAG or NTG
NCT07158970 — Home-Ultrasound in Routine High-Risk Care of Patients With Gestational Diabetes Mellitus (GDM)
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Wolfson Medical Center |
| Enrollment | 90 |
| Study Type | INTERVENTIONAL |
| Conditions | Gestational Diabetes Mellitus |
| Interventions |
This study evaluates the impact of incorporating home-ultrasound (home-US) devices into telemedicine care for patients with gestational diabetes mellitus (GDM). The study will compare satisfaction, clinical outcomes, and healthcare costs between standard high-risk pregnancy care and care augmented by home-US.
NCT07685015 — The Impact of Myo-Inositol on Glycemic Control and Oxidative Stress in Gestational Diabetes Mellitus
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Medical University of Vienna |
| Enrollment | 40 |
| Study Type | INTERVENTIONAL |
| Conditions | Gestational Diabetes Mellitus (GDM) |
| Interventions | ; ; |
The purpose of this clinical study is to investigate the potential effects of myo-inositol supplementation on changes in glycemic control parameters, oxidative stress, inflammatory biomarkers, psychometric markers, and body composition in participants with gestational diabetes mellitus (GDM).
The study duration is 3 to 3.5 months, depending on the time of GDM diagnosis. Before the active phase…
NCT07592273 — Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
| Status | Recruiting |
| Phase | Phase 2 / Phase 3 |
| Sponsor | AbbVie |
| Enrollment | 576 |
| Study Type | INTERVENTIONAL |
| Conditions | Diabetic Retinopathy |
| Interventions | ; ; |
Diabetic Retinopathy (DR) is a common eye condition caused by diabetes, where high blood sugar levels damage the blood vessels in the back part of the eye (called the retina). Over time, this damage can lead to vision problems and even blindness if not treated. This study will assess surabgene lomparvovec (sura-vec) as a potential one-time gene therapy administered in the suprachoroidal space (…
NCT07446205 — Poi for Mama: a Pilot to Improve Maternal Microbiome and Gestational Diabetes Risk
| Status | Recruiting |
| Phase | N/A |
| Sponsor | University of Hawaii |
| Enrollment | 50 |
| Study Type | INTERVENTIONAL |
| Conditions | Gestational Diabetes Mellitus (GDM); Pregnancy |
| Interventions |
This investigator-initiated, non-randomized pilot study evaluates the effect of daily consumption of fermented poi on the maternal microbiome and gestational diabetes risk during pregnancy. Fifty pregnant participants between approximately 12 and 24 weeks of gestation will receive one pound of poi daily for four weeks, accompanied by culturally tailored nutrition education delivered via secure …
NCT07619820 — A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)
| Status | Recruiting |
| Phase | Phase 1 |
| Sponsor | CSL Behring |
| Enrollment | 24 |
| Study Type | INTERVENTIONAL |
| Conditions | End Stage Kidney Disease (ESKD) |
| Interventions | ; |
This is a phase 1b, partial-blind (Sponsor unblinded), randomized, multicenter, placebo-controlled study. The primary objective of this study is to evaluate the pharmacokinetics (PK) of CSL300 after single and multiple doses in Chinese participants with end stage kidney disease (ESKD) undergoing dialysis.
NCT07351110 — Improving Cervical Cancer Prevention Among Women Living With Chronic Conditions.
| Status | Recruiting |
| Phase | N/A |
| Sponsor | University of Florida |
| Enrollment | 20 |
| Study Type | INTERVENTIONAL |
| Conditions | Diabetes; Cervical Cancer (Early Detection); Obesity & Overweight |
| Interventions |
Our overarching goal is to adapt and test the PINPOINT intervention -PatIent Navigation for the Prevention of CervIcal CaNcer inTervention. We will test the PINPOINT intervention among patients with high-risk profiles for cervical cancer who do not meet the recommended screening for cervical cancer.
Active, Not Recruiting
NCT00342927 — Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
| Status | Active, not recruiting |
| Phase | N/A |
| Sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Enrollment | 9084 |
| Study Type | OBSERVATIONAL |
| Conditions | Diabetic Nephropathy; Diabetes Mellitus; Diabetic Kidney Disease; Albuminuria |
The Family Investigation of Nephropathy and Diabetes (FIND) is a multicenter study designed to identify genetic determinants of diabetic kidney disease. FIND will be conducted in eleven centers and in many ethnic groups throughout the United States. Two different strategies will be used to localize genes predisposing to kidney disease: a family-based genetic linkage study and a case-control stu…
NCT03655223 — Early Check: Expanded Screening in Newborns
| Status | Active, not recruiting |
| Phase | N/A |
| Sponsor | RTI International |
| Enrollment | 30000 |
| Study Type | OBSERVATIONAL |
| Conditions | Spinal Muscular Atrophy; Fragile X Syndrome; Fragile X - Premutation; Duchenne Muscular Dystrophy; Hyperinsulinemic Hypoglycemia, Familial 1 |
| Interventions |
Early Check provides voluntary screening of newborns for a selected panel of conditions. The study has three main objectives: 1) develop and implement an approach to identify affected infants, 2) address the impact on infants and families who screen positive, and 3) evaluate the Early Check program. The Early Check screening will lead to earlier identification of newborns with rare health condi…
NCT05632601 — Reexamining Her Cardiovascular Risk - Ottawa WomeN’s Longitudinal Cohort Study
| Status | Active, not recruiting |
| Phase | N/A |
| Sponsor | Ottawa Heart Institute Research Corporation |
| Enrollment | 176 |
| Study Type | INTERVENTIONAL |
| Conditions | Cardiovascular Diseases |
| Interventions |
The full HER CROWN will be a prospective cohort study to propose a novel, women-specific cardiovascular risk score/ algorithm in the prediction of hard cardiovascular outcomes (myocardial infarction, unstable angina, coronary revascularization, stroke, total and cardiovascular mortality). This future study will be the first longitudinal cohort study, to our knowledge, that is focused entirely o…
NCT06321302 — A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Sponsor | Boehringer Ingelheim |
| Enrollment | 190 |
| Study Type | INTERVENTIONAL |
| Conditions | Diabetic Retinopathy |
| Interventions | ; ; |
This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join the study.
The purpose of this study is to find out whether a medicine called BI 764524 helps people with diabetic retinopathy. The study also aims to find a suitable treatment plan for BI 764524. Participants are put into 5 groups by chance. Part…
NCT06608212 — An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States
| Status | Active, not recruiting |
| Phase | N/A |
| Sponsor | Bayer |
| Enrollment | 150000 |
| Study Type | OBSERVATIONAL |
| Conditions | Chronic Kidney Disease; Type 2 Diabetes Mellitus |
| Interventions | ; |
This is an observational study in which data from people with chronic kidney disease (CKD) and Type 2 diabetes mellitus (T2D) are collected and studied.
In observational studies, only observations are made without participants receiving any advice or any changes to healthcare.
CKD is a long-term condition in which the kidneys’ ability to work properly gradually decreases over time. It is comm…
Not Yet Recruiting
NCT07682077 — Diabetes, Insulin, Gut, Enteric Supplementation Trial
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | University of New Brunswick |
| Enrollment | 60 |
| Study Type | INTERVENTIONAL |
| Conditions | Gestational Diabetes Mellitus (GDM); Blood Glucose; Insulin Resistance, Diabetes; Gut Microbiome; Gut Metabolites |
| Interventions |
Pregnancy is a critical window for metabolic health, and early changes in blood sugar regulation can increase the risk of gestational diabetes mellitus (GDM), which affects both maternal and infant health. At the same time, the maternal gut microbiome changes throughout pregnancy and may play a role in glucose metabolism and insulin resistance. Kefir, a fermented milk drink containing beneficia…
NCT07685119 — Effect of Resisted Blood Flow Restriction
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | Cairo University |
| Enrollment | 60 |
| Study Type | INTERVENTIONAL |
| Conditions | Diabetes Complication |
| Interventions |
The goal of this clinical trial is to investigate the effect of adding resisted blood flow restriction (BFR) training to a standard exercise program in adults aged 50-60 with Type 2 Diabetes Mellitus (T2DM). The main questions it aims to answer are:
Does adding BFR training significantly increase muscle strength compared to standard exercise alone? Does the BFR intervention lead to measurable …
NCT07313787 — Effects of Meal Macronutrients on Postprandial Lipids
| Status | Not yet recruiting |
| Phase | Phase 2 |
| Sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Enrollment | 100 |
| Study Type | INTERVENTIONAL |
| Conditions | Nephrotic Syndrome; Lipodystrophy; Metabolic Syndrome; Healthy Volunteer; Diabetes |
| Interventions | ; |
Background:
Abnormal fats in the blood can lead to many problems, including heart disease. Researchers want to learn more about how eating meals with different levels of nutrients affects fats in the blood. Specifically, they want to study people with too much body fat, too little body fat, and a kidney problem called nephrotic syndrome.
Objective:
To learn more about how different types of …
NCT07683598 — DLBS1033 as Adjunctive Therapy for Patients With Diabetic Neuropathy
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | RS H Adam Malik |
| Enrollment | 80 |
| Study Type | INTERVENTIONAL |
| Conditions | Diabetic Neuropathy |
| Interventions | ; |
This study will evaluate the effect of DLBS1033 as adjunctive therapy in patients with diabetic neuropathy. Diabetic neuropathy is a common complication of diabetes that can cause numbness, tingling, pain, impaired nerve function, and reduced quality of life.
Participants with diabetic neuropathy will be randomly assigned to receive either DLBS1033 plus standard therapy or placebo plus standar…
NCT07675720 — Concurrent Training vs Soleus Push-Ups on Neurogenesis-Related Biomarkers in Diabetic Neuropathy Patients
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | Riphah International University |
| Enrollment | 99 |
| Study Type | INTERVENTIONAL |
| Conditions | Diabetic Peripheral Neuropathy Type 2 |
| Interventions | ; |
This study will examine how two types of exercise programs affect nerve health in people with diabetic peripheral neuropathy. Diabetic peripheral neuropathy is a common complication of type 2 diabetes that can cause numbness, pain, balance problems, and reduced quality of life. Exercise is often recommended for people with diabetes, but it is not yet clear which types of exercise are most effec…
NCT07685886 — MIRACLE-T2D Montelukast Intervention for Renal, Cardiovascular and Eye Health in Type 2 Diabetes
| Status | Not yet recruiting |
| Phase | Phase 4 |
| Sponsor | University of Colorado, Denver |
| Enrollment | 110 |
| Study Type | INTERVENTIONAL |
| Conditions | Diabetes; Kidney Disease; Vascular Disease; Retinopathy |
| Interventions | ; |
Diabetes mellitus type 2 is associated with significant morbidity and mortality; and identifying new treatments for diabetes complications to be used alone or in combination with other therapies is a high priority. Hyperglycemia triggers proinflammatory pathways leading to damage in the kidneys, eyes and blood vessels; thus targeting proinflammatory lipid mediators called leukotrienes may repre…
NCT07686094 — Placental Cells for Diabetic Foot Ulcers
| Status | Not yet recruiting |
| Phase | Phase 1 |
| Sponsor | Wake Forest University Health Sciences |
| Enrollment | 12 |
| Study Type | INTERVENTIONAL |
| Conditions | Diabetic Foot Ulcer |
| Interventions |
The purpose of this research study is to test the safety of placental stem cells to treat non-healing diabetic foot ulcers.
Enrolling by Invitation
NCT04297592 — Antibiotic Prophylaxis in High-Risk Arthroplasty Patients
| Status | Enrolling by invitation |
| Phase | Phase 4 |
| Sponsor | Mayo Clinic |
| Enrollment | 4618 |
| Study Type | INTERVENTIONAL |
| Conditions | Infections Joint Prosthetic; Overweight or Obesity; MSSA Colonization; MRSA; Chronic Kidney Diseases |
| Interventions | ; ; |
To determine the effectiveness of a 7-day course of an oral, prophylactic antibiotic on the incidence of periprosthetic joint infection and wound complications following primary total hip and knee arthroplasty in a high-risk patient population.
NCT05472597 — Continuation of the nuMoM2b Heart Health Study
| Status | Enrolling by invitation |
| Phase | N/A |
| Sponsor | RTI International |
| Enrollment | 4048 |
| Study Type | OBSERVATIONAL |
| Conditions | Cardiovascular Diseases |
Cardiovascular disease (CVD) is the leading cause of mortality and morbidity in U.S. women at all ages, and large knowledge gaps exist in CVD predictive and preventative strategies for women. The nuMoM2b Heart Health Study (nuMoM2b-HHS) has followed a demographically diverse cohort of women enrolled and richly phenotyped during their first pregnancy, with data and biospecimens prospectively col…
Completed Trials
NCT04505566 — INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy Study
| Status | Completed |
| Phase | Phase 1 |
| Sponsor | Stephen J. Kim, MD |
| Enrollment | 164 |
| Study Type | INTERVENTIONAL |
| Conditions | Diabetic Retinopathy |
| Interventions | ; ; |
The central hypothesis is that inflammation mediators are biomarkers of both systemic diabetes and Diabetic Retinopathy (DR) progression in the aqueous and that sustained topical ketorolac application reduces/suppresses those inflammatory mediators thereby reducing the progression of Diabetic Retinopathy.
NCT04724330 — Pragmatic Randomized Clinical Trial to Limit Weight Gain in Pregnancy and Prevent Obesity
| Status | Completed |
| Phase | N/A |
| Sponsor | Johns Hopkins University |
| Enrollment | 534 |
| Study Type | INTERVENTIONAL |
| Conditions | Pregnancy Weight Gain; Postpartum Weight Retention; Childhood Obesity; Gestational Diabetes; Overweight and Obesity |
| Interventions |
Healthy for Two, Healthy for You (H42/H4U) is an innovative evidence-based pregnancy/postpartum health coach intervention that is remotely-delivered (phone coaching using motivational interviewing, web-based platform, mobile phone behavioral tracking). The aim of this randomized controlled trial (RCT) is to embed H42/H4U into Johns Hopkins prenatal care clinics that serve a racially and economi…
NCT05579743 — Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
| Status | Completed |
| Phase | N/A |
| Sponsor | Johns Hopkins University |
| Enrollment | 148 |
| Study Type | INTERVENTIONAL |
| Conditions | Diabetic Foot; Diabetic Foot Ulcer; Wound; Foot; Wound Leg; Wound Heal |
| Interventions |
The feasibility phase of the study was conducted to assess the feasibility of a novel, patient-centered, remote wound management system. The investigators will enroll 25 patients with an active diabetic foot ulcer (DFU) who present to the multidisciplinary diabetic foot clinic in Baltimore, Maryland.
The RCT is being done to compare two different methods of wound monitoring for chronic wounds:…
NCT05565716 — Supporting Self-Management of Healthy Behaviors in Diabetes, Kidney Disease, and Hypertension
| Status | Completed |
| Phase | N/A |
| Sponsor | University of Pennsylvania |
| Enrollment | 73 |
| Study Type | INTERVENTIONAL |
| Conditions | Renal Insufficiency, Chronic; Hypertension; Diabetes |
| Interventions | ; |
The planned intervention, entitled, Supporting Self-Management of Health Behaviors to Optimize Health (SMART-HABITS for Health), aims to provide support for patients with chronic kidney disease (CKD), hypertension and diabetes by providing text messages delivered as motivational reminders and support to encourage blood pressure self-monitoring through goal setting, customized task prompts via t…
NCT07005947 — Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project
| Status | Completed |
| Phase | N/A |
| Sponsor | CND Life Sciences |
| Enrollment | 237 |
| Study Type | OBSERVATIONAL |
| Conditions | Long COVID-19; Acute COVID-19; Postural Orthostatic Tachycardia Syndrome (POTS); Diabetic Neuropathy |
This is a prospective, longitudinal study involving 300 participants for a single visit to compare Long COVID-19 neurocutaneous biosignatures with those of other disorders affecting the sensory and autonomic nervous system.
NCT06127823 — Effect of Intensive Nutrition Training, Education, and Support in Gestational Diabetes - The INTENSE-GDM TRIAL
| Status | Completed |
| Phase | N/A |
| Sponsor | Steno Diabetes Center Copenhagen |
| Enrollment | 214 |
| Study Type | INTERVENTIONAL |
| Conditions | GDM; Gestational Diabetes; Nutritional and Metabolic Diseases; Nutrition Therapy; Medical Nutrition Therapy |
| Interventions |
The treatment of gestational diabetes (GDM) primarily revolves around consuming an optimal diet that does not cause blood glucose levels to become excessively high and provides an adequate supply of micro- and macronutrients without resulting in excessive weight gain during pregnancy. In some cases, it may become necessary to supplement with insulin during pregnancy. However, insulin treatment …
NCT07678944 — Impact of Exercise Prescription on Obstetric and Neonatal Outcomes
| Status | Completed |
| Phase | N/A |
| Sponsor | Unidade Local de Saúde de Coimbra, EPE |
| Enrollment | 310 |
| Study Type | INTERVENTIONAL |
| Conditions | Hypertension ,Pregnancy; Diabetes During Pregnancy; Obesity (BMI>30) |
| Interventions | ; |
The aim of this study is to assess the impact of structured physical activity with smartwatch remote monitoring on glycemic control, blood pressure control, obstetric complications and neonatal outcomes in women with GDM, chronic hypertension and obesity. A prospective, longitudinal, single-arm intervention study with 310 pregnant women was conducted over a period of 18 months. Participants rec…
NCT07255326 — Effect of Omega-3 Fatty Acids on Eye Blood Vessels in Type 1 Diabetes
| Status | Completed |
| Phase | N/A |
| Sponsor | University of Faisalabad |
| Enrollment | 70 |
| Study Type | INTERVENTIONAL |
| Conditions | Diabetic Retinopathy; Type 1 Diabetes; Omega 3 Fatty Acids |
| Interventions | ; |
This double-blind, placebo-controlled randomized clinical trial evaluates the effects of omega-3 fatty acid supplementation on retinal vascular structure and function in children and adolescents with type 1 diabetes. The study compares omega-3 supplementation with placebo to assess changes in retinal microvascular parameters, retinal blood flow, visual function, and systemic biomarkers over tim…
NCT07338773 — Intraosseous Versus Intravenous Vancomycin in Below-Knee Amputation for Ischemic Diabetic Foot
| Status | Completed |
| Phase | Phase 4 |
| Sponsor | Başakşehir Çam & Sakura City Hospital |
| Enrollment | 40 |
| Study Type | INTERVENTIONAL |
| Conditions | Diabetic Foot Disease; Diabetic Foot Infection; Diabetic Amputation Foot Wound |
| Interventions | ; |
This randomized clinical trial compared two routes of vancomycin administration in patients undergoing below-knee amputation for ischemic diabetic foot infection. Patients with diabetic foot infection and impaired lower-extremity circulation may have reduced delivery of intravenously administered antibiotics to the amputation stump. Intraosseous administration may increase local antibiotic expo…
NCT07690566 — Ultrasonic Enhancement Delivery of Phosphodiesterase Inhibitors Nanoparticles for Diabetic Management of the Foot
| Status | Completed |
| Phase | N/A |
| Sponsor | Deraya University |
| Enrollment | 1 |
| Study Type | INTERVENTIONAL |
| Conditions | Diabetic Foot |
| Interventions |
The enhancement of cGMP levels at the wound site has shown beneficial effects in wound healing. Thus, topical or systemic application of phosphodiesterase 5 (PDE5) inhibitors, for example, sildenafil (Viagra), which is well-known for its use in the treatment of erectile dysfunction, enhanced contraction, re-epithelialization, and tensile strength of rat wounds and reduced pressure ulcer size in…
Other (Suspended)
NCT01878045 — Mechanisms of Diabetic Kidney Disease in American Indians
| Status | Suspended |
| Phase | N/A |
| Sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Enrollment | 141 |
| Study Type | OBSERVATIONAL |
| Conditions | Nervous System; Diabetic Kidney Disease; Diabetes Mellitus, Type 2 |
Background:
- An ongoing study is looking at American Indians who have kidney problems caused by type 2 diabetes. Kidney disease due to type 2 diabetes is a major problem in American Indians. We previously found that early treatment of kidney disease with losartan was probably beneficial for reducing progression of the disease. Researchers now want to see if these benefits continue to be seen…
Other (Terminated)
NCT03523143 — The Effect of Early Screening and Intervention for Gestational Diabetes Mellitus on Pregnancy Outcomes
| Status | Terminated |
| Phase | N/A |
| Sponsor | National Taiwan University Hospital |
| Enrollment | 967 |
| Study Type | INTERVENTIONAL |
| Conditions | Pregnancy Complications; Gestational Diabetes Mellitus in Pregnancy |
| Interventions | ; |
Context: Women with gestational diabetes have excessive fetus growth weeks earlier than the screening period recommended currently, suggesting that earlier screening and intervention may improve pregnancy outcomes and the health of the offspring.
Objective: To determine if early screening and intervention could alter pregnancy outcomes, the incidence of maternal diabetes after delivery, and gr…
NCT04699864 — Evaluation of NeoRetina Artificial Intelligence Algorithm for the Screening of Diabetic Retinopathy at the CHUM
| Status | Terminated |
| Phase | N/A |
| Sponsor | Centre hospitalier de l’Université de Montréal (CHUM) |
| Enrollment | 24 |
| Study Type | INTERVENTIONAL |
| Conditions | Diabetic Retinopathy; Diabetic Macular Edema; Diabetic Maculopathy |
| Interventions | ; ; |
This prospective study aims to validate if NeoRetina, an artificial intelligence algorithm developped by DIAGNOS Inc. and trained to automatically detect the presence of diabetic retinopathy (DR) by the analysis of macula centered eye fundus photographies, can detect this disease and grade its severity.